Marinomed Biotech AG

Major Shareholding Notification • Feb 5, 2019

Publication Date: 05.02.2019 17:14 EANS-Voting Rights: Marinomed Biotech AG / Publication of a participation notification according to art. 135 para. 2 Stock Exchange Act

Notification of voting rights transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement.

Major holdings notification pursuant to Sec. 130 to 134 BörseG 2018 Wien, 4.2.2019

Overview

• 1. Issuer: Marinomed Biotech AG
• 1. Reason for the notification: Other
• 1. Person subject to notification obligation
• Andreas Grassauer
• 1. Name of shareholder(s):
• 1. Date on which the threshold was crossed or reached: 1.2.2019
• 1. Total positions

____________
		% of voting
	% of voting	rights through Total of both Total number of
	rights attached financial/other in % (7.A +			voting rights
	to shares (7.A) instruments		7.B)	of issuer
__ _______________ (7.B.1+7.B.2) __ __
Resulting
situation on
the date on	10,15 %	0,00 %	10,15 %	1 260 000
which threshold
was crossed /
_reached __ __ __ __
Position of
previous	10,15 %		10,15 %
notification
(if_applicable) __ __ __ ___

Details

1. Notified details of the resulting situation:

				____________
A:Voting_rights_attached_to_shares______
			_Numberof_voting_rights _______%of_voting_rights____
	Direct	Indirect	Direct	Indirect
ISIN Code				(Sec 130 BörseG (Sec 133 BörseG (Sec 130 BörseG (Sec 133 BörseG
				___ 2018)__ _2018) __2018)_ 2018)___
				ATMARINOMED6_ _127_841 _______________ ________10,15% ____
				SUBTOTAL_A__ ____________127_841____________ ____________10,15%_______

______________________________________________________________________________ |B 1: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 1 BörseG | |2018__________________________________________________________________________| | | | |Number of voting | | | | | | rights that may | | | Type of | | | be | % of voting | | instrument |Expiration Date|Exercise Period|acquired if the | rights | | | | | instrument is | | |_____________|_______________|_______________|____exercised____|______________| |_____________|_______________|_SUBTOTAL_B.1__|_________________|______________|

_____________________________________________________________________________

|B 2: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG | |2018_________________________________________________________________________|

Type of	Expiration Exercise		Physical /	Number of	% of voting
instrument	Date	Period	Cash	voting rights	rights
				__ _ ___________ Settlement__ ____ ______
				__ _ __ SUBTOTALB.2_ __ _

1. Information in relation to the person subject to the notification obligation: Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer. 9. In case of proxy voting Date of general meeting: - Voting rights after general meeting: - is equivalent to - voting rights. 10. Sonstige Kommentare: Erstmeldung wegen IPO Wien am 4.2.2019

end of announcement euro adhoc --------------------------------------------------------------------------------

issuer:	Marinomed Biotech AG
	Veterinärplatz 1
	A-1210 Wien
phone:	0043250774460
FAX:	0043250774493
mail:	office@marinomed.com
WWW:	www.marinomed.com
ISIN:	ATMARINOMED6, AT0000A1WD52
indexes:
stockmarkets: Wien
language:	English

Aussendung übermittelt durch euro adhoc
The European Investor Relations Service